QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 mizuho-downgrades-hologic-to-neutral-raises-price-target-to-78

Mizuho analyst Anthony Petrone downgrades Hologic (NASDAQ:HOLX) from Outperform to Neutral and raises the price target from ...

 raymond-james-downgrades-hologic-to-market-perform

Raymond James analyst Andrew Cooper downgrades Hologic (NASDAQ:HOLX) from Outperform to Market Perform.

 stephens--co-downgrades-hologic-to-equal-weight-lowers-price-target-to-76

Stephens & Co. analyst Mason Carrico downgrades Hologic (NASDAQ:HOLX) from Overweight to Equal-Weight and lowers the pri...

 jp-morgan-downgrades-hologic-to-neutral-announces-78-price-target

JP Morgan analyst Casey Woodring downgrades Hologic (NASDAQ:HOLX) from Overweight to Neutral and announces $78 price target.

 leerink-partners-maintains-market-perform-on-hologic-raises-price-target-to-78

Leerink Partners analyst Puneet Souda maintains Hologic (NASDAQ:HOLX) with a Market Perform and raises the price target from...

Core News & Articles

https://www.bloomberg.com/news/articles/2025-10-21/citi-barclays-among-banks-leading-hologic-12-billion-d

 hologic-agrees-to-183-billion-buyout-by-blackstone-and-tpg

Hologic shares rose after announcing an $18.3B buyout by Blackstone and TPG, including a $3 CVR linked to Breast Health revenue...

 needham-reiterates-hold-on-hologicto-hold

Needham analyst Mike Matson reiterates Hologic (NASDAQ:HOLX) from Hold to Hold.

Core News & Articles

- SEC Filing

 hologic-shares-resume-trade
Hologic Shares Resume Trade
10/21/2025 13:06:43

Core News & Articles

Hologic Stockholders to Receive $76 per Share in Cash Plus a Contingent Value Right of up to $3 per Share Payable Upon Achievin...

 evercore-isi-group-upgrades-hologic-to-outperform-raises-price-target-to-78

Evercore ISI Group analyst Vijay Kumar upgrades Hologic (NASDAQ:HOLX) from In-Line to Outperform and raises the price target...

 hologic-receives-fda-510k-clearance-and-ce-mark-for-panther-fusion-gastrointestinal-bacterial-and-expanded-bacterial-assays-to-enhance-rapid-diagnosis-of-infectious-gastroenteritis

New Panther Fusion Gastrointestinal Bacterial and Expanded Bacterial Assays deliver tailored, actionable diagnostic results to ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION